Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone
References (31)
- et al.
Randomized trial of interferon alfa-2b plus Ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 24 weeks versus interferon alfa-2b with and without ribavirin for treatment of chronic infection with hepatitis C
Lancet
(1998) - et al.
New treatment strategies in non-responder patients with chronic hepatitis C
J Hepatol
(1999) - et al.
Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C
Gastroenterology
(1997) - et al.
Ribavirin enhances efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centres
J Hepatol
(1997) - et al.
A pilot study of combination therapy with ribavirin plus in terferon alfa for interferon alfa resistant chronic hepatitis C
Gastroenterology
(1994) - et al.
Interferon-α. plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trial
J Hepatol
(1999) - et al.
A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France
J Hepatol
(1999) - et al.
Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial
Am J Med
(1999) - et al.
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha
Hepatology
(1997) - et al.
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy
J Hepatol
(1998)
Treatment of chronic hepatitis C with interferon alfa n-3: a multicenter, randomized, open label trial
Hepatology
(1997)
Response to higher doses of interferon alfa 2b in patients with chronic hepatitis C: a randomized multicenter trial
Hepatology
(1996)
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
Gastroenterology
(2000)
Natural history of chronic Hepatitis C
Ital J Gastroenterol Hepatol
(1999)
Cited by (8)
Management of hepatitis C in human immunodeficiency virus-infected patients
2002, Digestive and Liver DiseaseInterferon for interferon nonresponding and relapsing patients with chronic hepatitis C
2013, Cochrane Database of Systematic ReviewsCost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon
2003, Alimentary Pharmacology and TherapeuticsTreatment of chronic hepatitis C: A systematic review
2002, Hepatology
Copyright © 2001 Published by Elsevier Ltd.